NOV Antikörper (C-Term)
Kurzübersicht für NOV Antikörper (C-Term) (ABIN630288)
Target
Alle NOV Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- NOV antibody was raised against the C terminal of NOV
-
Aufreinigung
- Purified
-
Immunogen
- NOV antibody was raised using the C terminal of NOV corresponding to a region with amino acids KTIQAEFQCSPGQIVKKPVMVIGTCTCHTNCPKNNEAFLQELELKTTRGK
-
-
-
-
Applikationshinweise
-
WB: 5 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
NOV Blocking Peptide, (ABIN940066), is also available for use as a blocking control in assays to test for specificity of this NOV antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NOV antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NOV (Nephroblastoma Overexpressed (NOV))
-
Andere Bezeichnung
- NOV
-
Hintergrund
- As an immediate-early protein, NOV is likely to play a role in cell growth regulation.
-
Molekulargewicht
- 39 kDa (MW of target protein)
-
Pathways
- Smooth Muscle Cell Migration, Growth Factor Binding
Target
-